贵州信邦制药股份有限公司关于为控股子公司提供担保的公告

Group 1 - The company approved a total bank credit application of up to 210,000 million RMB for 2025, with a guarantee amount not exceeding 170,000 million RMB for its subsidiaries [2] - The company signed a guarantee contract with China Construction Bank for a subsidiary, Guizhou Tongde Pharmaceutical Co., Ltd., with a guarantee amount of 10,000 million RMB [3] - The board of directors stated that the guarantee risks are controllable and do not harm the interests of the company and its shareholders, especially minority shareholders [6] Group 2 - Guizhou Tongde Pharmaceutical Co., Ltd. has a registered capital of 9,750 million RMB and is involved in various business activities including the sale of agricultural products and traditional Chinese medicine [4] - The total external guarantee amount approved by the company is 170,000 million RMB, which accounts for 25.34% of the latest audited net assets [6] - After the current guarantee, the total balance of external guarantees is 87,000 million RMB, representing 12.97% of the latest audited net assets [6]